Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Apr;7(2):143-146.
doi: 10.21037/hbsn.2018.02.01.

Non-alcoholic fatty liver disease: beyond the liver is an emerging multifaceted systemic disease

Luigi Elio Adinolfi  1 , Aldo Marrone  1 , Luca Rinaldi  1
Affiliations
Editorial

Non-alcoholic fatty liver disease: beyond the liver is an emerging multifaceted systemic disease

Luigi Elio Adinolfi et al. Hepatobiliary Surg Nutr. 2018 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

References

    1. Loria P, Adinolfi LE, Bellentani S, et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis 2010;42:272-82. 10.1016/j.dld.2010.01.021 - DOI - PubMed
    1. Lonardo A, Nascimbeni F, Maurantonio M, et al. Nonalcoholic fatty liver disease: Evolving paradigms. World J Gastroenterol 2017;23:6571-92. 10.3748/wjg.v23.i36.6571 - DOI - PMC - PubMed
    1. Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73-84. 10.1002/hep.28431 - DOI - PubMed
    1. Sookoian S, Pirola CJ. Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Aliment Pharmacol Ther 2017;46:85-95. 10.1111/apt.14112 - DOI - PubMed
    1. Boursier J, Vergniol J, Guillet A, et al. Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease. J Hepatol 2016;65:570-8. 10.1016/j.jhep.2016.04.023 - DOI - PubMed

LinkOut - more resources